Virginia confirms its first locally acquired dengue case
Virginia health officials are investigating the state’s first documented locally acquired dengue infection in a Northern Virginia resident.
The Reality Check: Chelsea’s Mounting Troubles and the Neto Rumor Mill
Enzo Maresca has finally dropped the act, admitting he got it wrong regarding Cole Palmer’s recovery timeline. The Chelsea talisman, who has already…
A Transatlantic Disconnect: Hedging the Dow While the DAX Holds Ground
The June 29th session made it pretty obvious that traders are looking for cover stateside. We saw a decent amount of capital piling…
Xiaomi is Gunning for the Crown: The Upcoming K90 Ultra and the Relentless Spec Wars
Xiaomi is firing off a massive warning shot in the battle for smartphone supremacy, and they aren’t just aiming at the mid-range anymore….
The Dollar Squeeze: Gold Slips Below $4,000 as Fed Hawks Take Flight
Gold is officially taking a beating, tumbling to multi-month lows and slicing right through the $4,000 mark for the first time in over…
The Great Lineup Shakeup: Why the iPhone 17’s Pricing Trap is Just a Warm-Up for Apple’s Foldable Future
Every fall, we expect the exact same drill: a new iPhone drops, and last year’s base models get a neat $100 price cut,…
Rewiring the Academy: Bold Play for AI-Centric Higher Education
Digital transformation in higher education is overdue for a redefinition. For years, universities treated “going digital” as an exercise in layering traditional IT…
High-Stakes Anfield Clash: Injuries Mount for Arsenal as Liverpool Eyes Defensive Reinforcements
Both Arsenal and Liverpool have blasted out of the gate this season, setting up a massive early title race showdown at Anfield. The…
Biopharma Watch: Rhythm Pharmaceuticals Crushes Q4 Estimates as Incannex Healthcare Shows Late-Day Strength
Rhythm Pharmaceuticals (RYTM) delivered a surprisingly robust financial performance for the fourth quarter of 2025. The company reported an EPS of -$0.73, comfortably…